Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03424005
Title A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Metastatic or Inoperable Locally Advanced Triple-Negative Breast Cancer (Morpheus-TNBC) (Morpheus-TNBC)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Hoffmann-La Roche

triple-receptor negative breast cancer


Atezolizumab + Bevacizumab + Selicrelumab

Atezolizumab + RO6874281

Atezolizumab + Bevacizumab

Atezolizumab + Carboplatin + Gemcitabine

Atezolizumab + Eribulin



Atezolizumab + Bevacizumab + Cobimetinib

Atezolizumab + Capecitabine

Atezolizumab + Ipatasertib

Atezolizumab + Ladiratuzumab vedotin

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.